tiprankstipranks
Fate Therapeutics (DE:F6T)
FRANKFURT:F6T
Germany Market

Fate Therapeutics (F6T) Income Statement

Compare
0 Followers

Fate Therapeutics Income Statement

Last quarter (Q4 2024), Fate Therapeutics's total revenue was $1.86M, an increase of 10.98% from the same quarter last year. In Q4, Fate Therapeutics's net income was $-52.15M. See Fate Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 13.63M$ 63.53M$ 96.30M$ 55.85M$ 31.43M
Gross Profit
$ 13.63M$ -98.16M$ 82.54M$ 50.00M$ -94.19M
Operating Expenses
$ 223.91M$ 254.04M$ 404.69M$ 272.84M$ 159.52M
Depreciation and Amortization
$ 18.96M$ 18.28M$ 13.76M$ 5.85M$ 3.09M
EBITDA
$ -176.58M$ -172.23M$ -294.63M$ -211.14M$ -125.00M
Operating Income
$ -210.28M$ -190.51M$ -308.39M$ -216.99M$ -128.09M
Other Income/Expenses
$ 24.01M$ 29.58M$ 26.66M$ 4.84M$ -45.30M
Pretax Income
$ -186.26M$ -160.93M$ -281.72M$ -212.15M$ -173.39M
Net Income
$ -186.26M$ -160.93M$ -255.06M$ -206.30M$ -170.30M
Per Share Metrics
Basic EPS
$ -1.64$ -1.64$ -2.63$ -2.18$ -2.07
Diluted EPS
$ -1.64$ -1.64$ -2.63$ -2.18$ -2.07
Weighted Average Shares Outstanding
113.69M 98.41M 96.83M 94.75M 82.39M
Weighted Average Shares Outstanding (Diluted)
113.69M 98.41M 96.83M 94.75M 82.39M
Currency in USD

Fate Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis